Evaluation of 4 methods for the serological diagnosis of Epstein-Barr virus infection using an immunofluorescence assay as the reference method

Turkish Journal of Medical Sciences

Volumn 44, Issue 6, 2014, Pages 914-919

  Koçoğlu, Mücahide Esra ^a   Taş, Tekin ^a   Mengeloğlu, Fırat Zafer ^a   Özsoy, Şeyda ^a   Bucak, Özlem ^a  

^a ABANT IZZET BAYSAL UNIVERSITY   (Turkey)

Author keywords

ELISA; Epstein Barr virus; Immunoblot assay; Immunochromatographic assay

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; VIRUS ANTIBODY;

ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE CLASSIFICATION; ENZYME LINKED FLUORESCENT ASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPSTEIN BARR VIRUS INFECTION; EVALUATION STUDY; GOLD STANDARD; HUMAN; IMMUNOAFFINITY CHROMATOGRAPHY; IMMUNOBLOTTING; IMMUNOFLUORESCENCE TEST; MAJOR CLINICAL STUDY; NONHUMAN; PRIMARY INFECTION; SENSITIVITY AND SPECIFICITY; STANDARD; VIRUS REACTIVATION; ENZYME IMMUNOASSAY; EPSTEIN-BARR VIRUS INFECTIONS; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOASSAY; IMMUNOLOGY; NICK END LABELING; PROCEDURES;

ANTIBODIES, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPSTEIN-BARR VIRUS INFECTIONS; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOASSAY; IMMUNOCHROMATOGRAPHY; IMMUNOENZYME TECHNIQUES; IN SITU NICK-END LABELING; SENSITIVITY AND SPECIFICITY;

EID: 84908067979     PISSN: 13000144     EISSN: None     Source Type: Journal    
DOI: 10.3906/sag-1308-38     Document Type: Article

References (18)

1. Rickinson AB, Kief E. Epstein-Barr virus. In: Fields BN, Knipe DM, Howley PM, editors. Virology. 3rd ed. New York, NY, USA: Raven Press; 1996. pp. 2397–2446.
2. Linde A, Falk K: Epstein-Barr virus. In: Murray PR, editor. Manual of Clinical Microbiology. 9th ed. Washington, DC, USA: ASM Press; 2007. pp. 1564–1573.
3. Bell AT, Fortune B, Sheeler R. Clinical inquiries. What test is the best for diagnosing infectious mononucleosis? J Fam Pract 2006; 55: 799–802.
4. Llor C, Hernández M, Hernández S, Martínez T, Gómez FF. Validity of a point-of-care based on heterophile antibody detection for the diagnosis of infectious mononucleosis in primary care. Eur J Gen Pract 2012; 18: 15–21.
5. Fisher BA, Bhalara S. False-positive result provided by rapid heterophile antibody test in a case of acute infection with hepatitis E virus. J Clin Microbiol 2004; 42: 4411.
6. Hess RD. Routine Epstein–Barr virus diagnostics from the laboratory perspective: still challenging afer 35 years. J Clin Microbiol 2004; 42: 3381–3387.
7. Buisson M, Fleurent B, Mak M, Morand P, Chan L, Ng A, Guan M, Chin D, Seigneurin JM. Novel immunoblot assay using four recombinant antigens for diagnosis of Epstein-Barr virus primary infection and reactivation. J Clin Microbiol 1999; 37: 2709–2714.
8. Klutts JS, Ford BA, Gronowski AM. Evidence-based approach for interpretation of Epstein-Barr virus serological patterns. J Clin Microbiol 2009; 47: 3204–3210.
9. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977; 33: 159–174.
10. Altuglu I, Bozkurt H, Samlioglu P, Zeytinoglu A. Evaluation of three different assays for the assessment of Epstein-Barr virus immunological status. New Microbiol 2007; 30: 393–398.
11. Koidl C, Riedl R, Schweighofer B, Fett S, Bozic M, Marth E. Performance of new enzyme-linked fluorescent assays for detection of Epstein-Barr virus specific antibodies in routine diagnostics. Wien Klin Wochenschr 2011; 123: 230–234.
12. Sener AG, Afsar I, Pinar E. Evaluation of Epstein-Barr virus antibodies, anti-VCA avidity by immunofuorescence and immunoblot assays for assessment of Epstein-Barr virus immunologic state. J Virol Methods 2009; 159: 300–302.
13. Lupo J, Germi R, Semenova T, Buisson M, Seigneurin JM, Morand P. Performance of two commercially available automated immunoassays for the determination of Epstein-Barr virus serological status. Clin Vaccine Immunol 2012; 19: 929–934.
14. Rea TD, Ashley RL, Russo JE, Buchwald DS. A systematic study of Epstein-Barr virus serologic assays following acute infection. Am J Clin Pathol 2002; 117: 156–161.
15. Feng Z, Li Z, Sui B, Xu G, Xia T. Serological diagnosis of infectious mononucleosis by chemiluminescent immunoassay using capsid antigen p18 of Epstein-Barr virus. Clin Chim Acta 2005; 354: 77–82.
16. De Ory F, Guisasola ME, Sanz JC, García-Bermejo I. Evaluation of four commercial systems for the diagnosis of Epstein-Barr virus primary infections. Clin Vaccine Immunol 2011; 18: 444–448.
17. Devanthery O, Meylan P. Comparison of a multiplexed bead-based assay with an immunofuorescence and an enzyme-immuno assay for the assessment of Epstein–Barr virus serologic status. Clin Microbiol Infect 2010; 16: 1776–1782.
18. Gärtner BC, Hess RD, Bandt D, Kruse A, Rethwilm A, Roemer K, Mueller-Lantzsch N. Evaluation of four commercially available Epstein-Barr virus enzyme immunoassays with an immunofuorescence assay as the reference method. Clin Diagn Lab Immunol 2003; 10: 78–82.